Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Yeon Sarah Han

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Review of Proteomics|February 23, 2018
Proteomic approaches to identify blood-based biomarkers for depression and bipolar disordersRhian Lauren Preece, Sung Yeon Sarah Han, Sabine Bahn
Translational Psychiatry|November 9, 2019
Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individualsSung Yeon Sarah Han, Jason D Cooper, Sureyya Ozcan, et al.
Translational Psychiatry|February 13, 2019
Multimodel inference for biomarker development: an application to schizophreniaJason D Cooper, Sung Yeon Sarah Han, Jakub Tomasik, et al.
JMIR Formative Research|October 28, 2021
Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation StudyNayra A Martin-Key, Dan-Mircea Mirea, Tony Olmert, et al.
Brain and Behavior|May 7, 2021
The Delta Study - Prevalence and characteristics of mood disorders in 924 individuals with low mood: Results of the of the World Health Organization Composite International Diagnostic Interview (CIDI)Nayra A Martin-Key, Tony Olmert, Giles Barton-Owen, et al.
JAMA Psychiatry|October 25, 2023
Metabolomic Biomarker Signatures for Bipolar and Unipolar DepressionJakub Tomasik, Scott J Harrison, Nitin Rustogi, et al.
JMIR Research Protocols|August 11, 2020
A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational StudyTony Olmert, Jason D Cooper, Sung Yeon Sarah Han, et al.
JMIR Mental Health|February 22, 2021
Impact of a Web-Based Psychiatric Assessment on the Mental Health and Well-Being of Individuals Presenting With Depressive Symptoms: Longitudinal Observational StudyDan-Mircea Mirea, Nayra A Martin-Key, Giles Barton-Owen, et al.
Journal of Affective Disorders|October 28, 2021
Personality, symptom, and demographic correlates of perceived efficacy of selective serotonin reuptake inhibitor monotherapy among current users with low mood: A data-driven approachJiri Benacek, Nayra A Martin-Key, Giles Barton-Owen, et al.
Brain, Behavior, and Immunity|August 31, 2020
Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low moodSung Yeon Sarah Han, Jakub Tomasik, Nitin Rustogi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Review of Proteomics|February 23, 2018
Proteomic approaches to identify blood-based biomarkers for depression and bipolar disordersRhian Lauren Preece, Sung Yeon Sarah Han, Sabine Bahn
Translational Psychiatry|November 9, 2019
Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individualsSung Yeon Sarah Han, Jason D Cooper, Sureyya Ozcan, et al.
Translational Psychiatry|February 13, 2019
Multimodel inference for biomarker development: an application to schizophreniaJason D Cooper, Sung Yeon Sarah Han, Jakub Tomasik, et al.
JMIR Formative Research|October 28, 2021
Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation StudyNayra A Martin-Key, Dan-Mircea Mirea, Tony Olmert, et al.
Brain and Behavior|May 7, 2021
The Delta Study - Prevalence and characteristics of mood disorders in 924 individuals with low mood: Results of the of the World Health Organization Composite International Diagnostic Interview (CIDI)Nayra A Martin-Key, Tony Olmert, Giles Barton-Owen, et al.
JAMA Psychiatry|October 25, 2023
Metabolomic Biomarker Signatures for Bipolar and Unipolar DepressionJakub Tomasik, Scott J Harrison, Nitin Rustogi, et al.
JMIR Research Protocols|August 11, 2020
A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational StudyTony Olmert, Jason D Cooper, Sung Yeon Sarah Han, et al.
JMIR Mental Health|February 22, 2021
Impact of a Web-Based Psychiatric Assessment on the Mental Health and Well-Being of Individuals Presenting With Depressive Symptoms: Longitudinal Observational StudyDan-Mircea Mirea, Nayra A Martin-Key, Giles Barton-Owen, et al.
Journal of Affective Disorders|October 28, 2021
Personality, symptom, and demographic correlates of perceived efficacy of selective serotonin reuptake inhibitor monotherapy among current users with low mood: A data-driven approachJiri Benacek, Nayra A Martin-Key, Giles Barton-Owen, et al.
Brain, Behavior, and Immunity|August 31, 2020
Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low moodSung Yeon Sarah Han, Jakub Tomasik, Nitin Rustogi, et al.
Pageof 2